T1	Participants 58 79	hypertensive patients
T2	Participants 413 634	Patients with sitting diastolic blood pressure (siDBP) â‰¥90 mmHg with 4 weeks of once-daily fimasartan 60 mg were randomly assigned to receive either once-daily fimasartan 60 mg/HCTZ 12.5 mg or fimasartan 60 mg for 4 weeks
T3	Participants 827 910	263 randomized patients, 256 patients who had available efficacy data were analyzed
